We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Vita 34 AG (V3V) NPV

Sell:€4.04 Buy:€4.36 Change: €0.08 (2.00%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:€4.04
Buy:€4.36
Change: €0.08 (2.00%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:€4.04
Buy:€4.36
Change: €0.08 (2.00%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Vita 34 AG, formerly, Vita 34 International AG, is a Germany-based company operating in the medical technology sector and acts as a cell bank/stem cell bank. The Company is involved in the long-term storage and processing of stem cells from human umbilical cord blood. The cells are collected during the child’s birth and can be used later in his or her life for the treatment of many diseases, such as anemia, diabetes, degenerative joint diseases, cancer, neurological deficits after brain injuries, cartilage damages and others. They also allow the growing of whole organs, such as the liver. On average, one out seven individuals, whose cells are stored, receives autologous stem cell transplant by the age of 70. The Company acts as a cord blood bank and is also engaged in research activities around regenerative medicine, including curing the consequences of strokes and heart attacks. The Company operates in Germany, Spain, and Denmark.

Contact details

Address:
Deutscher Platz 5a
LEIPZIG
04103
Germany
Telephone:
+49 (341) 4879240
Website:
https://www.vita34.de/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
V3V
ISIN:
DE000A0BL849
Market cap:
€74.09 million
Shares in issue:
17.43 million
Sector:
Health Care Services
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Alexander Granderath
    Independent Chairman of the Supervisory Board
  • Wolfgang Knirsch
    Chairman of the Management Board, Chief Executive Officer
  • Florian Schuhbauer
    Independent Deputy Chairman of the Supervisory Board
  • Andreas Schafhirt
    Chief Financial Officer, Member of the Management Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.